Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
9 studies found for:    benzamide
Show Display Options
Rank Status Study
1 Completed Benzamide Derivates as Treatment of Clozapine-induced Hypersalivation
Condition: Clozapine-induced Hypersalivation
Intervention: Drug: Amisulpride, Moclobemide
2 Completed Metoclopramide as Treatment of Clozapine-induced Hypersalivation
Condition: Clozapine-induced Hypersalivation
Interventions: Drug: Metoclopramide;   Drug: placebo
3 Completed Safety and Pharmacokinetics of SAR240550 (BSI-201) Twice Weekly in Patients With Advanced Solid Tumors
Condition: Advance Solid Tumors
Interventions: Drug: Iniparib (SAR240550 - BSI-201);   Drug: Gemcitabine;   Drug: Carboplatin
4 Completed
Has Results
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031)
Condition: Chemotherapy-Induced Nausea and Vomiting (CINV)
Interventions: Drug: Fosaprepitant dimeglumine;   Drug: Fosaprepitant Placebo;   Drug: Dexamethasone;   Drug: Ondansetron;   Drug: Dexamethasone Placebo;   Drug: Ondansetron Placebo;   Drug: Rescue Therapy
5 Completed Feasibility of 123I-IBZM Scintigraphy (a D2 Agonist) in Patients With Pheochromocytoma (PHEO) and/or Paraganglioma (PGL) : Study Pilot
Condition: Chromaffin-tissue Derived Tumors
Intervention: Other: Scintigraphy in 123I-IBZM
6 Recruiting Study of VSN16R for the Treatment of Spasticity in Multiple Sclerosis
Condition: Spasticity in People With Multiple Sclerosis
Interventions: Drug: VSN16R;   Other: Placebo
7 Completed An Open-label Study Investigating the Disposition and QT/QTc Interval Effects of 400 mg [14C]-Iniparib(3.7 MBq, 100 µCi)
Condition: Advanced Solid Tumors
Intervention: Drug: Iniparib
8 Completed
Has Results
A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225) (KMEC)
Conditions: Nausea;   Vomiting
Interventions: Drug: Aprepitant;   Drug: Aprepitant Placebo;   Drug: Ondansetron;   Drug: Dexamethasone;   Drug: Ondansetron Placebo;   Drug: Rescue Therapy (granisetron, dolasetron, tropisetron or ondansetron; metoclopramide or alizapride).
9 Completed Study of Aprepitant (MK-0869) for Chemotherapy-Induced Nausea and Vomiting (CINV) in Adolescent Participants (MK-0869-097)
Condition: Vomiting
Interventions: Drug: aprepitant;   Drug: ondansetron;   Drug: dexamethasone;   Drug: placebo to aprepitant;   Drug: placebo to dexamethasone;   Drug: rescue medication

Study has passed its completion date and status has not been verified in more than two years.